Ai Genomics - Revision history

Wordpad: BloomWiki: Ai Genomics

2026-04-25T01:46:55Z

BloomWiki: Ai Genomics

← Older revision		Revision as of 01:46, 25 April 2026
Line 1:		Line 1:
			<div style="background-color: #4B0082; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
	{{BloomIntro}}		{{BloomIntro}}
	AI for genomics and bioinformatics applies machine learning to the analysis of biological sequence data — DNA, RNA, and proteins — to understand the genetic basis of life, disease, and evolution. The sequencing revolution has generated petabytes of genomic data; extracting biological meaning from this data requires sophisticated computational tools. AI now drives breakthroughs in predicting protein structure (AlphaFold), identifying disease-causing genetic variants, designing new genes and proteins, and understanding gene regulation. Genomics AI is transforming medicine, agriculture, and our fundamental understanding of biology.		AI for genomics and bioinformatics applies machine learning to the analysis of biological sequence data — DNA, RNA, and proteins — to understand the genetic basis of life, disease, and evolution. The sequencing revolution has generated petabytes of genomic data; extracting biological meaning from this data requires sophisticated computational tools. AI now drives breakthroughs in predicting protein structure (AlphaFold), identifying disease-causing genetic variants, designing new genes and proteins, and understanding gene regulation. Genomics AI is transforming medicine, agriculture, and our fundamental understanding of biology.
			</div>

	== Remembering ==		__TOC__

			<div style="background-color: #000080; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Remembering</span> ==
	* '''Genome''' — The complete set of DNA in an organism, containing all genetic information.		* '''Genome''' — The complete set of DNA in an organism, containing all genetic information.
	* '''DNA sequencing''' — Determining the order of nucleotide bases (A, T, G, C) in a DNA molecule.		* '''DNA sequencing''' — Determining the order of nucleotide bases (A, T, G, C) in a DNA molecule.
Line 18:		Line 23:
	* '''Polygenic risk score (PRS)''' — An ML-derived score aggregating many small-effect genetic variants to predict disease risk.		* '''Polygenic risk score (PRS)''' — An ML-derived score aggregating many small-effect genetic variants to predict disease risk.
	* '''CRISPR''' — A gene editing technology; AI assists in designing guide RNAs and predicting off-target effects.		* '''CRISPR''' — A gene editing technology; AI assists in designing guide RNAs and predicting off-target effects.
			</div>

	== Understanding ==		<div style="background-color: #006400; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Understanding</span> ==
	Genomics is inherently a machine learning problem: biological sequences are discrete strings over small alphabets (A, T, G, C for DNA; 20 amino acids for proteins), and the relationship between sequence and function is complex, non-linear, and learned from evolutionary history across billions of years.		Genomics is inherently a machine learning problem: biological sequences are discrete strings over small alphabets (A, T, G, C for DNA; 20 amino acids for proteins), and the relationship between sequence and function is complex, non-linear, and learned from evolutionary history across billions of years.

Line 29:		Line 36:

	'''Polygenic Risk Scores (PRS)''': Aggregating thousands of small-effect genetic variants into a single disease risk score. Modern PRS methods use penalized regression (LASSO) and Bayesian approaches on GWAS summary statistics. PRS can predict cardiovascular disease, type 2 diabetes, and schizophrenia risk years before clinical onset.		'''Polygenic Risk Scores (PRS)''': Aggregating thousands of small-effect genetic variants into a single disease risk score. Modern PRS methods use penalized regression (LASSO) and Bayesian approaches on GWAS summary statistics. PRS can predict cardiovascular disease, type 2 diabetes, and schizophrenia risk years before clinical onset.
			</div>

	== Applying ==		<div style="background-color: #8B0000; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Applying</span> ==
	'''Protein secondary structure prediction with a sequence transformer:'''		'''Protein secondary structure prediction with a sequence transformer:'''
	<syntaxhighlight lang="python">		<syntaxhighlight lang="python">
Line 68:		Line 77:
	: '''CRISPR design''' → CRISPR-ML (off-target prediction), DeepCRISPR		: '''CRISPR design''' → CRISPR-ML (off-target prediction), DeepCRISPR
	: '''Genomics pipelines''' → Bioconductor (R), Scanpy/Seurat (single-cell), GATK (variant calling)		: '''Genomics pipelines''' → Bioconductor (R), Scanpy/Seurat (single-cell), GATK (variant calling)
			</div>

	== Analyzing ==		<div style="background-color: #8B4500; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Analyzing</span> ==
	{\| class="wikitable"		{\| class="wikitable"
	\|+ Genomics AI Application Maturity		\|+ Genomics AI Application Maturity
Line 88:		Line 99:

	'''Failure modes''': Batch effects — systematic technical differences between sequencing batches can dominate biological signal. Genetic ancestry bias — GWAS and PRS trained predominantly on European-ancestry populations perform poorly for other groups. Data leakage from protein databases (model trained on homologous sequences performs poorly on truly novel proteins). Interpretation of non-coding variants remains extremely challenging.		'''Failure modes''': Batch effects — systematic technical differences between sequencing batches can dominate biological signal. Genetic ancestry bias — GWAS and PRS trained predominantly on European-ancestry populations perform poorly for other groups. Data leakage from protein databases (model trained on homologous sequences performs poorly on truly novel proteins). Interpretation of non-coding variants remains extremely challenging.
			</div>

	== Evaluating ==		<div style="background-color: #483D8B; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Evaluating</span> ==
	Genomics AI evaluation requires domain-specific rigor:		Genomics AI evaluation requires domain-specific rigor:
	# '''Held-out proteins/genes''': ensure no homologous sequences in test set (sequence identity <30%).		# '''Held-out proteins/genes''': ensure no homologous sequences in test set (sequence identity <30%).
Line 96:		Line 109:
	# '''Benchmark databases''': CASP (protein structure), ClinVar (variant pathogenicity), GenomicsDB (GWAS hits).		# '''Benchmark databases''': CASP (protein structure), ClinVar (variant pathogenicity), GenomicsDB (GWAS hits).
	# '''Interpretability''': which genomic features does the model rely on? Should match known biology.		# '''Interpretability''': which genomic features does the model rely on? Should match known biology.
			</div>

	== Creating ==		<div style="background-color: #2F4F4F; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
			== <span style="color: #FFFFFF;">Creating</span> ==
	Designing a genomics AI pipeline for disease risk prediction:		Designing a genomics AI pipeline for disease risk prediction:
	# Data: obtain UK Biobank or similar population cohort GWAS summary statistics.		# Data: obtain UK Biobank or similar population cohort GWAS summary statistics.
Line 109:		Line 124:
	[[Category:Genomics]]		[[Category:Genomics]]
	[[Category:Bioinformatics]]		[[Category:Bioinformatics]]
			</div>

Wordpad: BloomWiki: Ai Genomics

2026-04-23T14:35:52Z

BloomWiki: Ai Genomics

← Older revision		Revision as of 14:35, 23 April 2026
Line 90:		Line 90:

	== Evaluating ==		== Evaluating ==
	Genomics AI evaluation requires domain-specific rigor: ~~(1)~~ '''Held-out proteins/genes''': ensure no homologous sequences in test set (sequence identity <30%). ~~(2)~~ '''Cross-ancestry validation''': evaluate PRS performance separately in different ancestry groups. ~~(3)~~ '''Wet lab validation''': computational predictions must be validated experimentally; paper predictions vs. experimental outcomes. ~~(4)~~ '''Benchmark databases''': CASP (protein structure), ClinVar (variant pathogenicity), GenomicsDB (GWAS hits). ~~(5)~~ '''Interpretability''': which genomic features does the model rely on? Should match known biology.		Genomics AI evaluation requires domain-specific rigor:
			# '''Held-out proteins/genes''': ensure no homologous sequences in test set (sequence identity <30%).
			# '''Cross-ancestry validation''': evaluate PRS performance separately in different ancestry groups.
			# '''Wet lab validation''': computational predictions must be validated experimentally; paper predictions vs. experimental outcomes.
			# '''Benchmark databases''': CASP (protein structure), ClinVar (variant pathogenicity), GenomicsDB (GWAS hits).
			# '''Interpretability''': which genomic features does the model rely on? Should match known biology.

	== Creating ==		== Creating ==
	Designing a genomics AI pipeline for disease risk prediction: ~~(1)~~ Data: obtain UK Biobank or similar population cohort GWAS summary statistics. ~~(2)~~ PRS construction: use PRS-CS or LDpred2 for Bayesian shrinkage estimation across all common variants. ~~(3)~~ Validation: validate PRS in independent cohort with different ancestry background. ~~(4)~~ Clinical integration: combine PRS with clinical risk factors (age, BMI, family history) using a joint logistic regression model. ~~(5)~~ Calibration: recalibrate model for target population; generate risk percentile scores. ~~(6)~~ Ethical review: ensure compliance with genomic data privacy regulations (HIPAA, GDPR); obtain IRB approval for clinical use.		Designing a genomics AI pipeline for disease risk prediction:
			# Data: obtain UK Biobank or similar population cohort GWAS summary statistics.
			# PRS construction: use PRS-CS or LDpred2 for Bayesian shrinkage estimation across all common variants.
			# Validation: validate PRS in independent cohort with different ancestry background.
			# Clinical integration: combine PRS with clinical risk factors (age, BMI, family history) using a joint logistic regression model.
			# Calibration: recalibrate model for target population; generate risk percentile scores.
			# Ethical review: ensure compliance with genomic data privacy regulations (HIPAA, GDPR); obtain IRB approval for clinical use.

	[[Category:Artificial Intelligence]]		[[Category:Artificial Intelligence]]
	[[Category:Genomics]]		[[Category:Genomics]]
	[[Category:Bioinformatics]]		[[Category:Bioinformatics]]

Wordpad: BloomWiki: Ai Genomics

2026-04-23T14:20:31Z

BloomWiki: Ai Genomics

New page

{{BloomIntro}}
AI for genomics and bioinformatics applies machine learning to the analysis of biological sequence data — DNA, RNA, and proteins — to understand the genetic basis of life, disease, and evolution. The sequencing revolution has generated petabytes of genomic data; extracting biological meaning from this data requires sophisticated computational tools. AI now drives breakthroughs in predicting protein structure (AlphaFold), identifying disease-causing genetic variants, designing new genes and proteins, and understanding gene regulation. Genomics AI is transforming medicine, agriculture, and our fundamental understanding of biology.

== Remembering ==
* '''Genome''' — The complete set of DNA in an organism, containing all genetic information.
* '''DNA sequencing''' — Determining the order of nucleotide bases (A, T, G, C) in a DNA molecule.
* '''Single Nucleotide Polymorphism (SNP)''' — A single base-pair variation in the genome; billions of SNPs exist in the human population.
* '''GWAS (Genome-Wide Association Study)''' — A statistical study associating genetic variants with traits or diseases across many individuals.
* '''Variant calling''' — The computational process of identifying genetic variants from sequencing data.
* '''RNA-seq''' — Sequencing RNA molecules to measure gene expression levels across the genome.
* '''Gene expression''' — The process by which information from a gene is used to synthesize gene products (RNA, proteins).
* '''Protein structure prediction''' — Predicting the 3D shape of a protein from its amino acid sequence.
* '''AlphaFold''' — DeepMind's revolutionary AI system for protein structure prediction; solved the 50-year protein folding problem.
* '''Sequence alignment''' — Comparing biological sequences to identify regions of similarity; fundamental to all bioinformatics.
* '''k-mer''' — A subsequence of length k; used to represent genomic sequences as features for ML models.
* '''Epigenomics''' — The study of heritable changes in gene expression not caused by DNA sequence changes; includes DNA methylation and histone modification.
* '''Single-cell sequencing''' — Measuring gene expression in individual cells rather than bulk tissue; reveals cellular heterogeneity.
* '''Polygenic risk score (PRS)''' — An ML-derived score aggregating many small-effect genetic variants to predict disease risk.
* '''CRISPR''' — A gene editing technology; AI assists in designing guide RNAs and predicting off-target effects.

== Understanding ==
Genomics is inherently a machine learning problem: biological sequences are discrete strings over small alphabets (A, T, G, C for DNA; 20 amino acids for proteins), and the relationship between sequence and function is complex, non-linear, and learned from evolutionary history across billions of years.

'''The protein folding revolution''': For 50 years, predicting a protein's 3D structure from its amino acid sequence was considered one of biology's grand challenges. DeepMind's AlphaFold2 (2020) solved this with near-experimental accuracy, using a combination of multiple sequence alignment, equivariant attention networks, and self-supervised learning on known protein structures. AlphaFold has predicted structures for virtually all known proteins — ~200M structures — in the AlphaFold Protein Structure Database, transforming drug discovery.

'''Genomic language models''': BERT-style transformers pre-trained on DNA sequences learn rich representations of genomic function. Models like Enformer predict gene expression from DNA sequence by learning the regulatory grammar encoded in non-coding regions. DNABERT, Nucleotide Transformer, and Evo (trained on billions of DNA sequences) have achieved state-of-the-art on diverse genomic prediction tasks.

'''Single-cell AI''': scRNA-seq measures gene expression in individual cells, generating sparse high-dimensional count matrices (cells × genes). AI tools like Seurat and Scanpy cluster cells by type; foundation models for single-cell data (scGPT, Geneformer) enable zero-shot cell type annotation, perturbation prediction, and drug response modeling.

'''Polygenic Risk Scores (PRS)''': Aggregating thousands of small-effect genetic variants into a single disease risk score. Modern PRS methods use penalized regression (LASSO) and Bayesian approaches on GWAS summary statistics. PRS can predict cardiovascular disease, type 2 diabetes, and schizophrenia risk years before clinical onset.

== Applying ==
'''Protein secondary structure prediction with a sequence transformer:'''
<syntaxhighlight lang="python">
from transformers import AutoTokenizer, AutoModelForTokenClassification
import torch

# ESM-2: Facebook's protein language model
# Fine-tuned for secondary structure prediction (Helix/Sheet/Coil per residue)
tokenizer = AutoTokenizer.from_pretrained("facebook/esm2_t33_650M_UR50D")
model = AutoModelForTokenClassification.from_pretrained(
"facebook/esm2_t33_650M_UR50D",
num_labels=3 # H (helix), E (sheet), C (coil)
)

# Protein sequence
protein = "MKTAYIAKQRQISFVKSHFSRQLEERLGLIEVQAPILSRVGDGTQDNLSGAEKAVQVKVKALPDAQFEVVHSLAKWKRQTLGQHDFSAGEGLYTHMKALRPDEDRLSPLHSVYVDQWDWERVMGDGERQFSTLKSTVEAIWAGIKATEAAVSEEFGLAPFLPDQIHFVHSQELLSRYPDLDAKGRERAIAKDLGAVFLVGIGGKLSDGHRHDVRAPDYDDWSTPSELGHAGLNGDILVWNPVLEDAFELSSMGIRVDADTLKHQLALTGDEDRLELEWHQALLRGEMPQTIGGGIGQSRLTMLLLQLPHIGQVQAGVWPAAVRESVPSLL"
inputs = tokenizer(protein, return_tensors="pt")

with torch.no_grad():
outputs = model(**inputs)
predictions = outputs.logits.argmax(dim=-1)[0][1:-1] # Remove CLS/EOS

labels = {0: "H", 1: "E", 2: "C"}
structure = "".join([labels[p.item()] for p in predictions])
print(f"Sequence: {protein[:50]}...")
print(f"Structure: {structure[:50]}...")

# AlphaFold for full 3D structure (use via ColabFold for accessible inference)
# from colabfold.run import run
# run(queries=[("protein", protein)], result_dir="./structures/")
</syntaxhighlight>

; Genomics AI tools and resources
: '''Protein structure''' → AlphaFold2/3 (ColabFold for easy access), ESMFold, RoseTTAFold
: '''Gene expression''' → Enformer (sequence → expression), Geneformer, scGPT
: '''Variant interpretation''' → DeepVariant (variant calling), PrimateAI (pathogenicity)
: '''CRISPR design''' → CRISPR-ML (off-target prediction), DeepCRISPR
: '''Genomics pipelines''' → Bioconductor (R), Scanpy/Seurat (single-cell), GATK (variant calling)

== Analyzing ==
{| class="wikitable"
|+ Genomics AI Application Maturity
! Application !! AI Approach !! Clinical Use || Key Metric
|-
| Protein structure prediction || AlphaFold (transformer + MSA) || Drug design || TM-score (>0.7 = reliable)
|-
| Variant pathogenicity || Ensemble ML, deep learning || Clinical genetics || AUC on ClinVar benchmarks
|-
| Cancer genomics || CNN on somatic mutations || Research/clinical || Driver gene identification accuracy
|-
| PRS disease risk || Penalized regression, Bayesian || Research → clinical || C-statistic (AUC)
|-
| scRNA-seq cell typing || Clustering + transfer learning || Research || F1 on held-out datasets
|-
| CRISPR off-target prediction || CNN, transformers || Research || AUROC on off-target sites
|}

'''Failure modes''': Batch effects — systematic technical differences between sequencing batches can dominate biological signal. Genetic ancestry bias — GWAS and PRS trained predominantly on European-ancestry populations perform poorly for other groups. Data leakage from protein databases (model trained on homologous sequences performs poorly on truly novel proteins). Interpretation of non-coding variants remains extremely challenging.

== Evaluating ==
Genomics AI evaluation requires domain-specific rigor: (1) '''Held-out proteins/genes''': ensure no homologous sequences in test set (sequence identity <30%). (2) '''Cross-ancestry validation''': evaluate PRS performance separately in different ancestry groups. (3) '''Wet lab validation''': computational predictions must be validated experimentally; paper predictions vs. experimental outcomes. (4) '''Benchmark databases''': CASP (protein structure), ClinVar (variant pathogenicity), GenomicsDB (GWAS hits). (5) '''Interpretability''': which genomic features does the model rely on? Should match known biology.

== Creating ==
Designing a genomics AI pipeline for disease risk prediction: (1) Data: obtain UK Biobank or similar population cohort GWAS summary statistics. (2) PRS construction: use PRS-CS or LDpred2 for Bayesian shrinkage estimation across all common variants. (3) Validation: validate PRS in independent cohort with different ancestry background. (4) Clinical integration: combine PRS with clinical risk factors (age, BMI, family history) using a joint logistic regression model. (5) Calibration: recalibrate model for target population; generate risk percentile scores. (6) Ethical review: ensure compliance with genomic data privacy regulations (HIPAA, GDPR); obtain IRB approval for clinical use.

[[Category:Artificial Intelligence]]
[[Category:Genomics]]
[[Category:Bioinformatics]]